Drug Profile
KRH 594
Alternative Names: WK 1492; WK 14922KLatest Information Update: 16 May 2000
Price :
$50
*
At a glance
- Originator Wakunaga Pharmaceutical
- Developer Kissei Pharmaceutical; Wakunaga Pharmaceutical
- Class Antihypertensives; Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic nephropathies; Heart failure; Hypertension
Most Recent Events
- 16 May 2000 KRH 594 is available for licensing worldwide (http://www.wakunaga.co.jp)
- 16 May 2000 Discontinued-II for Hypertension in Japan (PO)
- 16 May 2000 Discontinued-Preclinical for Diabetic nephropathies in Japan (PO)